Accelmed Files Transaction Statementon Schedule 13E-3 with Securities and Exchange Commission
–News Direct–
Today Minerva Surgical, Inc. (the Company) (Nasdaq: UTRS), entered into a share purchase agreement (the Purchase Agreement) for the sale of an aggregate of 97,751,711 shares (the Shares) of its common stock (Common Stock) in a private placement (the Private Placement) by the Company to Accelmed Partners II L.P. (Accelmed LP), at an offering price of $0.2046 per share, for aggregate consideration of $20,000,000.07.
In connection with a contemplated refinancing by the Company of its Loan and Security Agreement, dated as of October 8, 2021, by and among the Company, the Canadian Imperial Bank of Commerce, and each other person party thereto, as a borrower from time to time, as amended (the Loan and Security Agreement, and such refinancing, the Refinancing), it is expected that...